Eisai Steps Well ‘Beyond The Pill’ In New Japan Care Service
Japanese major Eisai is working with a communications company for a new online system in Japan that will more closely link chronic disease patients and medical care providers, with a number of expected benefits including treatment compliance that could potentially help stem sales declines for two mainstay products.
You may also be interested in...
Japanese pharma firm’s new venture capital fund aims to support and gain access to external innovation both at home and in the US, while a new alliance with a Japanese tech services firm will pursue opportunities in digital health and dementia.
The still somewhat loosely defined concept of 'digital health' continues to take concrete forms through recent deals in Japan, where major pharma firms are building initiatives related mainly to patient well-being.
New venture DigiTx will give Astellas a leg up in its quest to access novel digital health technologies, in a move unveiled as the Japanese firm reported continued strong growth for top product Xtandi.